Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Ribociclib
Sponsor: Georgetown University
Collaborators: Medstar Health Research Institute|Breast Cancer Research Foundation|Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS)